[HTML][HTML] Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols

MY Ansari, N Ahmad, TM Haqqi - Biomedicine & pharmacotherapy, 2020 - Elsevier
Osteoarthritis (OA) is the most prevalent joint degenerative disease leading to irreversible
structural and functional changes in the joint and is a major cause of disability and reduced …

Emerging pharmaceutical therapies for osteoarthritis

A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …

The IL-1 family of cytokines and receptors in rheumatic diseases

CA Dinarello - Nature Reviews Rheumatology, 2019 - nature.com
More than any other cytokine family, the 11 members of the IL-1 family are associated with
innate immune responses, which occur in acute inflammation and chronic inflammatory …

Interleukin-1β signaling in osteoarthritis–chondrocytes in focus

Z Jenei-Lanzl, A Meurer, F Zaucke - Cellular Signalling, 2019 - Elsevier
Osteoarthritis (OA) can be regarded as a chronic, painful and degenerative disease that
affects all tissues of a joint and one of the major endpoints being loss of articular cartilage. In …

Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis

Z Chen, H Zhong, J Wei, S Lin, Z Zong, F Gong… - Arthritis research & …, 2019 - Springer
Introduction Osteoarthritis (OA) is an inflammatory disease of the joints that causes
progressive disability in the elderly. Reactive oxygen species (ROS) play an important role …

Cartilage calcification in osteoarthritis: mechanisms and clinical relevance

I Bernabei, A So, N Busso, S Nasi - Nature Reviews Rheumatology, 2023 - nature.com
Pathological calcification of cartilage is a hallmark of osteoarthritis (OA). Calcification can be
observed both at the cartilage surface and in its deeper layers. The formation of calcium …

A phase II trial of lutikizumab, an anti–interleukin‐1α/β dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis

RM Fleischmann, H Bliddal, FJ Blanco… - Arthritis & …, 2019 - Wiley Online Library
Objective To assess the efficacy and safety of the anti–interleukin‐1α/β (anti–IL‐1α/β) dual
variable domain immunoglobulin lutikizumab (ABT‐981) in patients with knee osteoarthritis …

[HTML][HTML] Pyroptosis plays a role in osteoarthritis

S An, H Hu, Y Li, Y Hu - Aging and disease, 2020 - ncbi.nlm.nih.gov
Recent studies have revealed novel forms of cell death beyond the canonical types of
cellular apoptosis and necrosis, and these novel forms of cell death are induced by extreme …

Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee

CS Cook, PA Smith - Current reviews in musculoskeletal medicine, 2018 - Springer
Abstract Purpose of Review The purpose of this review is to update the reader on the current
applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This …

[HTML][HTML] Identifying effector molecules, cells, and cytokines of innate immunity in OA

MHJ Van den Bosch, P Van Lent… - Osteoarthritis and …, 2020 - Elsevier
Inflammatory changes are observed in affected joints of osteoarthritis (OA) patients and are
thought to be involved in the pathology that develops along OA progression. This narrative …